Effect of sympatholytic agents on cardiovascular, respiratory and glottal changes during the apnoeic reflex of nasal origin.
D000818:Animals; D001049:Apnea / Q000503:physiopathology*; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D004877:Ergoloid Mesylates / Q000494:pharmacology; D005931:Glottis / Q000187:drug effects*; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D009297:Nasal Mucosa / Q000503:physiopathology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011817:Rabbits; D012021:Reflex, Abnormal; D012119:Respiration / Q000187:drug effects; D012137:Respiratory System / Q000187:drug effects*; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*
D013565:Sympatholytics; D010643:Phenoxybenzamine; D004877:Ergoloid Mesylates; D006145:Guanethidine